Division of Insurance Medicine
Sickness absence affects individuals, health care, insurance organizations, employers, and society. Nevertheless, the scientific knowledge base is very limited. We conduct research, systematic literature reviews, post graduate training, and networking regarding sickness absence, work disability, health, and living conditions.
New grant to the Division of Insurance Medicine
New grant to the Division of Insurance Medicine
Jurgita Narusyte has been granted 4.9 million SEK from AFA Insurance within the research program “Living and working with mental ill-health”. The overall purpose of the funded project is to investigate the associations between mental ill-health and sickness absence among individuals employed in the private sector.
Jurgita Narusyte has been granted 2.4 million SEK
Jurgita Narusyte has been granted 2.4 million SEK
Jurgita Narusyte has been granted 2.4 million SEK from the Swedish Research Council for a project on the associations between mental health problems in emerging adulthood and future sickness absence among those working in public and private sectors.
Ellenor Mittendorfer-Rutz was inaugurated as a professor
Ellenor Mittendorfer-Rutz was inaugurated as a professor
Ellenor Mittendorfer-Rutz was inaugurated as KI´s first professor in Insurance Medicine during a ceremony held in Aula Medica.
"We represent many disciplines within medical science, but we are united in the aim of improving people’s health,” said Ellenor Mittendorfer-Rutz in her professor’s speech.
Kristin Farrants has been granted 1.8 milllion SEK
Kristin Farrants has been granted 1.8 milllion SEK
Kristin Farrants has been granted 1.8 million SEK from Handelsrådet for a project regarding sickness absence and disability pension among white-collar workers in trade. The project will consist of cohort studies with a 5-year follow-up based on linked register data.
Call for Abstracts
Call for Abstracts
The EUMASS Congress is one of the major international research and learning events in insurance medicine in Europe.
The congress will take place in Basel in Switzerland 17-19 September 2020.
The theme is “Science and practice in the field of insurance medicine – present and future challenges in the European and Swiss context."
You can submit your abstract the latest on 14 December 2019.
Annina Ropponen has been granted 4.7 million SEK
Annina Ropponen has been granted 4.7 million SEK
Annina Ropponen has been granted 4.7 million SEK from Forte for a research project regarding the associations between early life factors and sustainable working life using twin design.
Emilie Friberg has been granted 5 million SEK
Emilie Friberg has been granted 5 million SEK
Emilie Friberg has been granted 5 million SEK for a project about multiple sclerosis (MS), gainful employment and sick leave from Försäkringskassan.
The project is expected to generate important knowledge that is often requested by doctors and patients about strategies for being able to work as long as possible.
Karolinska Institutet has now a professor in Insurance Medicine!
Karolinska Institutet has now a professor in Insurance Medicine!
Ellenor Mittendorfer-Rutz has begun her position as a Professor of Insurance Medicine at the Division of Insurance Medicine, the Department of Clinical Neuroscience at Karolinska Institutet in April this year. The research area of insurance medicine is relatively new, however, it has developed much during the last years. Karolinska Institutet has taken a leading role in this development both nationally and internationally – a role that will be even more pronounced now.
New VR grant to the Division of Insurance Medicine
New VR grant to the Division of Insurance Medicine
Ellenor Mittendorfer-Rutz, Professor and Head of the Division of Insurance Medicine has been granted 25,000,000 SEK by the Swedish Research Council for a research environment called REMAIN (”Refugee Minors And INtegration”). Five research groups from four different countries are involved in the research environment. The aim is to establish knowledge and find strategies to improve the social integration of refugees minors with mental disorders.
New study shows that long-term medication for schizophrenia is safe
New study shows that long-term medication for schizophrenia is safe
Researchers at Karolinska Institutet and their colleagues in Germany, the USA and Finland have studied the safety of very long-term antipsychotic therapy for schizophrenia. According to the study, which is published in the scientific journal World Psychiatry, mortality was higher during periods when patients were not on medication than when they were.
Agreement on the new European Data Protection Legislation good for research
Agreement on the new European Data Protection Legislation good for research
The European parliament, the Council of Ministers, and the European Commission have agreed on a common text which will replace national legislations on data protection by 2018 (PUL in Sweden).
Cochrane Insurance Medicine
Cochrane Insurance Medicine
Now Cochrane Insurance Medicine (CIM) is established as a field within Cochrane.
CIM aims to establish and make evidence based knowledge regarding insurance medicine available for professionals and users.
The Division of Insurance Medicine has, together with groups from three other countries, since many years worked to establish this as a field within Cochrane.